Back
Harte-Hanks Vs. Neurogene Industry Stock Comparison
Sell
25
HHS
Harte-Hanks
Last Price:
$5.35
Seasonality Move:
5.28%
Sell
10
NGNE
Neurogene
Last Price:
$22.69
Seasonality Move:
18.83%
Sell
25
Harte-Hanks (HHS)
is a Sell
Is Harte-Hanks a Buy, Sell or Hold?
-
The current Harte-Hanks [HHS] share price is $5.36. The Score for HHS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
HHS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HHS Stock Price Chart
What is Harte-Hanks's stock price today?
-
The Harte-Hanks share price today is $5.36Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HHS is experiencing selling pressure, which indicates risk of future bearish movement.
NGNE Stock Price Chart
HHS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 32.64 | Sell |
Chaikin Money Flow: | -7886 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.51 - 5.97) | Sell |
Bollinger Bands (100): | (6.19 - 7.71) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.45 | Sell |
Relative Strength Index (14 RSI): | 39.99 | Sell |
Chaikin Money Flow: | 17850 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.49 - 25.09) | Buy |
Bollinger Bands (100): | (25.92 - 49.92) | Sell |
HHS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.57 | Sell |
20-day SMA: | 5.69 | Sell |
50-day SMA: | 6.43 | Sell |
200-day SMA: | 7.27 | Sell |
8-day EMA: | 5.52 | Sell |
20-day EMA: | 5.75 | Sell |
50-day EMA: | 6.26 | Sell |
200-day EMA: | 7.06 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.96 | Sell |
20-day SMA: | 23.45 | Sell |
50-day SMA: | 36.87 | Sell |
200-day SMA: | 37.81 | Sell |
8-day EMA: | 22.84 | Sell |
20-day EMA: | 25.05 | Sell |
50-day EMA: | 31.73 | Sell |
200-day EMA: | 34.89 | Sell |
Harte-Hanks Earnings Growth & HHS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.50 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
Harte-Hanks Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |